NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Nolte E, Knai C, editors. Assessing Chronic Disease Management in European Health Systems: Country reports [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2015. (Observatory Studies Series, No. 39.)
Assessing Chronic Disease Management in European Health Systems: Country reports [Internet].
Show details5.1. The health care system
The Estonian health care system is governed by the Ministry of Social Affairs. It involves several actors, including the Health Board, formed in 2010, and the Estonian Health Insurance Fund (EHIF). Health care funding is principally through SHI, which covers approximately 95% of the population. Contributions are related to employment, with non-contributing individuals (such as children and pensioners) representing almost half of the insured population. SHI accounted for 69.1% of total health expenditure in 2012, complemented by taxation (10.8%) and OOP payments (18.4%) (WHO, 2014). In 2012, health expenditure was 5.9% of GDP. OOP payments are mainly for pharmaceuticals and dental care.
The EHIF is the main purchaser of health care services. The Ministry of Social Affairs is responsible for financing emergency care for uninsured people, ambulance services and public health programmes, funded from the state budget. The role of municipalities in health financing is small (Couffinhal & Habicht, 2005; Habicht, 2008; Habicht & Habicht, 2008). EHIF funds are collected centrally to balance regional disparities in income. Most health care funds are allocated to four regional EHIF departments; pharmaceutical and temporary sick leave benefits are administered centrally, as is a small fraction for selected expensive or infrequent procedures such as bone marrow transplants, peritoneal dialysis and some oncology and haematological treatments.
The EHIF contracts with licensed providers in primary care, specialist outpatient and inpatient care. These are typically public sector providers although contracting with licensed private providers is possible. General conditions are negotiated with provider associations such as the Society of Family Physicians and the Hospital Association, for a period of five years. Individual provider contracts determine service volumes and total costs by specialty.
Citizens have free choice of GP, with whom they register. GPs principally have a gatekeeping function, with direct access to specialists granted for a small number of specialties and follow-up consultation for a chronic disease.
GPs are paid through a combination of basic allowance, capitation fee, and fee-for-service, with an additional compensation for those practising in more remote areas.
Hospitals are owned by the state, local government and other public organizations; they provide outpatient and inpatient services (Government of the Republic of Estonia, 2002). Payment is on the basis of DRGs, implemented from 2004 and complementing fee-for-service payments.
Health care reforms of relevance to chronic disease
Following independence, Estonia introduced, in 1992, a social security system to ensure a sound revenue base for the health care system (Jesse et al., 2004; Koppel et al., 2008; Lai et al., 2013). In parallel, Estonia began to implement a primary care system based on the principles of general practice, replacing the previous system which comprised of polyclinics and ambulatory care, owned by the municipalities and by a few private providers. The 1997 primary care reform plan set out to expand primary care to cover the whole population with family physician services by 2003. In 1998, some primary care planning functions were recentralized from the municipality to the county level. Increasing access to primary care formed an important precondition for downsizing the hospital network and centralizing specialist care. The framework for family medicine is now a distinct part of the 2001 Health Service Organization Act (Government of the Republic of Estonia, 2002).
The 1990s also saw a reform of the pharmaceutical sector, involving, among other things, the introduction of an essential drug list, a system for drug reimbursement, based on disease severity, medication efficacy, and ability to pay, and the privatization of pharmaceutical services (for example, pharmacies).
The early 1990s further saw a restructuring of the hospital sector, with the introduction of quality standards and a licensing system. The Hospital Master Plan 2015, issued in 2000, projected a reduction by two-thirds of the number of hospitals (from 68 to 15), a reduction by two-thirds in the number of acute care inpatient beds and the concentration of acute inpatient care in 15 large hospitals by 2015 (Habicht, Aaviksoo & Koppel, 2006). Complementing the reduction in the number of acute care beds, a system for rehabilitation and long-term care was to be developed. The process of reforming the hospital system is ongoing, with small hospitals being turned into nursing homes or primary care centres for outpatient care (Government of the Republic of Estonia, 2011; Ministry of Social Affairs, 2004).
Current legal, regulatory and policy frameworks
While the management of chronic diseases as a concept is not explicitly addressed in health policy documents, the overall set-up and structure of health care does support chronic disease management. One of the stated goals of health care system restructuring was the need to provide for chronic disease management, with the GP acting as principal coordinator in primary care.
In 2005, the EHIF introduced a bonus payment system for GPs as an incentive to support disease prevention and the management of selected chronic conditions (see below). In 2009, a new framework for assessing the performance of GP practices was adopted by the Estonian Family Medicine Association, including guidelines for evaluation processes, types and indicators.
The overall approach is supported by a system of evidence-based clinical guidelines, driven by medical associations in cooperation with the EHIF (Ravijuhend, 2014). There are widely accepted treatment guidelines for diabetes, chronic heart disease, multiple sclerosis and others (59 for 21 specialties).
Strategic plans have been developed to support primary care nursing, home care nursing and GPs on questions of chronic disease management including ways to improve and coordinate patient access to all levels of health care, rehabilitation and social care (Eesti Õdede Liit, Eesti Haigekassa & Eesti Gerontoloogia ja Geriaatria Assotsiatsioon, 2004; Eesti Õdede Liit, 2008). These development plans provide a long-term strategic vision for the specialty and are thus distinct from activity guidelines that provide guidance for day-to-day work.
More recently, in 2008, the Estonian government adopted the National Health Plan (NHP) 2009–2020 (Ministry of Social Affairs, 2008). Its main objective was to increase life expectancy for men and women respectively to 75 and 84 years by 2020. The NHP sets out five strategic areas with specific objectives, sub-objectives and measurable target indicators for each, including social cohesion and equal opportunities; safe and healthy development for children and youth; a living, working and learning environment to support health; healthy lifestyle; and the development of a high-quality and accessible health care system. It further specifies health care targets, such as the development of a patient-centred health care system through better patient information and coordination between the different levels of health care; the availability of high-quality health care services through the development of primary medical services, optimization of the active care hospital network and the development of nursing/welfare care; and the long-term sustainability of health care funding that protects patients from financial risk. Chronic disease management is not specifically addressed by the NHP although it addresses prerequisites and general principles for structured approaches.
5.2. Approaches to chronic disease management
As noted above, a key component of the Estonian health care system is the central role of GPs in overall patient management and care coordination. This is accompanied by well-developed information systems with the GP as principal holder of patient data on all medical services, including hospital care. Overall, there are three main forms of chronic disease management in Estonia: quality management in primary health care; chronic disease management at the interface between primary and secondary care; and other activities within primary care (for all other diseases).
Quality management in primary health care
The central disease management role of GPs is supported by a bonus payment system to encourage the prevention and management of chronic conditions. This payment system was established, in 2006, for type 2 diabetes and cardiovascular diseases.
Type 2 diabetes
The system covers all diagnosed diabetes cases in GP practices. The quality of diabetes care is continuously monitored by the EHIF and GP practices according to the GP diabetes care quality management and practice evaluation frameworks. The framework sets specific rules on the number of consultations, the nature, volume and frequency of tests required by various age–gender–disease severity groups of type 2 diabetes. A financial incentive is provided to GP practices in the quality management framework for diabetes care. Disease management in primary care is also linked to specialist diabetes centres that provide additional support for more severe disease cases. These specialist care units combine out- and inpatient care with nurse-led ‘foot clinics’ and collaborate closely with dieticians and social care workers.
Chronic cardiovascular diseases
The bonus system covers all diagnosed cardiovascular diseases cases in Estonia. The main setting is the GP practice but it also includes specialist care, community (patient groups) and the social care system. The quality of cardiovascular diseases care is continuously monitored by EHIF and GP practices according to the GP cardiovascular diseases care quality management and practice evaluation frameworks. It is actively encouraged by EHIF, which provides additional financial incentives in line with a care quality management framework, which sets specific rules for the number of nurse consultations, the nature, volume and frequency of tests required by various age–gender–disease severity groups of cardiovascular diseases.
The impact of the diabetes and cardiovascular diseases quality management system on the overall performance of the health care system has not been assessed so far. The system is voluntary for GPs and in 2012 about 97% of GP practices had joined. The proportion of GPs achieving set targets continues to increase, pointing to improved disease management and more systematic referral patterns among GPs while the target thresholds and number of indicators are continuously increased and adapted.
Chronic disease management at the primary/secondary care interface
Multiple sclerosis
Three regional care centres form the focal points for the structured management of patients with multiple sclerosis; it covers all diagnosed cases with the disease in Estonia. The system is funded within the regular system but there is no specific funder-driven encouragement for the structured management of multiple sclerosis. Social care services are financed separately by the Estonian Social Insurance Board.
Parkinson’s disease
The development of the structured management of patients with Parkinson’s disease began simultaneously in the community and health care sectors, as a bottom-up initiative. The Estonian Parkinson’s Association was created, bringing together Parkinson’s patients, family members, doctors and representatives of Parkinson’s related specialties.
Schizophrenia
The development of the structured management of patients with schizophrenia was on professional initiative with support from patient organizations. It covers all patients diagnosed with schizophrenia in Estonia and all GP practices. The quality of schizophrenia treatment/care is in line with international guidelines and is continuously monitored by service providers.
COPD
The structured management of COPD was developed as a professional initiative. It covers all patients diagnosed with COPD in GP practices. The approach is funded within the framework that governs all other health care providers in Estonia.
The main setting for the structured management of these conditions is the care centre or the hospital where the majority of activities are performed in the outpatient setting. The system also spans primary care, social care and community patient groups.
The main strategies employed are very similar regardless of the disease. They involve elements of self-management support, delivery system design, decision support and clinical information systems.
- Self-management support refers to patient education provided in primary care settings by any member of the primary care team (generally a GP or family nurse) but can also be provided in a specialist care setting in more severe disease cases. Patients are involved in developing their individualized care plans, which cover consultations by other specialists for improved management of co-morbidities according to patient condition and needs. For some conditions, the wider community may be involved in supporting patients, such as the Parkinson’s Association for patients diagnosed with this condition, including the provision of information materials, lectures, practical training as well as mentoring and practical everyday support. All patients have regular assessments based on their health status. Additionally, all patients have direct access to a GP for unscheduled visits in case of disease relapses.
- Delivery system design includes case finding with referral to specialist care. There is an important role for teamwork and integrated care for providing (personalized) rehabilitation for conditions such as Parkinson’s disease. Teams comprise of psychiatrists, social workers, and rehabilitation and other specialists. Regular assessments and follow-up are part of the treatment process which commences following confirmed diagnosis.
- Decision support entails the use of evidence-based guidelines and specialist expertise provided within international networks. For example, the multiple sclerosis centres work within the framework of international multiple sclerosis associations that provide expertise and second opinion if needed. Provider education is part of the continuous professional development of GPs. In case of type 2 diabetes and cardiovascular diseases, a quality management system for follow-up and GP practice evaluation is in place.
- Clinical information systems are employed to support disease management. For example, the information system used in the multiple sclerosis centre is part of a larger system that includes electronic booking and information systems for the acute care hospital, its outpatient care, rehabilitation and long-term care units. The electronic system is connected to the patient and treatment information system that covers all health care providers in Estonia. From September 2009, the system has been supplemented by an electronic patient record system that links all service provider-based patient records into one network and thus enables electronic access to all patient data (including laboratory tests and imaging) regardless of the place where the data were generated.
Evaluation
Evaluation of structured disease management activities in Estonia is not consistent and systematic, owing to staff shortages, lack of funding, resistance from policy-makers, health professionals and funders, and the limited availability of valid and reliable data. Lack of awareness of the need for programme evaluation among policy-makers (and also health professionals) is probably the foremost barrier to implementation of programmes evaluations. This is at least partially caused by the fact that there is no overall chronic disease development policy in Estonia which also highlights low level of stewardship in this area provided by the Ministry of Social Affairs.
However, EHIF has provided incentives for regular quality assessments within primary care. The main indicators of effect are improved patient outcomes, survival and satisfaction. Process measures relating to referral rates and clinical measures are regularly monitored, as are the costs of existing care centres. Additional external evaluations can be performed by the EHIF as part of the cardiovascular care quality management framework and is currently performed annually on a random sample of GP practices.
Since 2010, evaluations of GP practices have been performed by the Estonian Society of Family Doctors and a list of the 20 highest ranking practices is also published (Estonian Health Insurance Fund, 2010).
5.3. A patient journey
This section describes the journey of two hypothetical typical patients with co-morbid chronic disease in the Estonian health care system.
(A) A 54-year-old woman with type 2 diabetes and COPD who has a leg ulcer and moderate retinopathy. The patient is slightly overweight (BMI of 27). She has been unemployed for three years and receives social assistance benefits; she lives on her own.
The patient is covered by social insurance and has direct and free access to a GP. She also has free access to specialist care but needs a GP referral for that.
Thus, the first diagnosis of both diabetes and COPD generally comes from the patient’s GP, according to national diagnosis and treatment guidelines. Both diagnosed diseases can be managed solely by the GP, but given the evident disease severity and co-morbidities, it is likely that the patient will be referred to an endocrinologist and pulmonologist. The specialist appointment is generally made by the patient, but for the patient in this case study, it is more likely made by the GP or a nurse in the practice.
Depending on the disease severity assessment by the specialist, the patient can be referred for hospitalization, scheduled for routine treatment in ambulatory specialist care or referred back to GP for treatment with a verified diagnosis and specialist input. Regardless of the next steps for treatment, all consultation results are channelled back to the GP.
The patient described in this case study is most likely to remain under the care of both the GP and an endocrinologist. The GP coordinates the patient’s overall treatment and the primary management of diabetes, and oversees to some degree the follow-up of specialist care, for example, by providing reminders of specialist consultations. The GP also refers the patient to nurse-led ‘foot clinics’ while the specialist schedules follow-up visits for specialist care if needed. The specialist may also refer the patient to any other specialist although this is generally performed by the GP and the information is shared among providers.
The social assistance benefit in this case is most likely a form of disability benefit requested for the patient by the GP. Both GP and specialist may contact social care workers to ask that the patient be considered for social care services, although this is most likely made by the GP. The same also applies to referrals for rehabilitation services. A daily lifestyle consultation is provided by the GP or primary care nurse and is supported by disease-specific lifestyle advice from an endocrinologist and pulmonologist (and other specialists if need be).
Overall, the allocation of treatment responsibilities between GP and specialist is largely dependent on specific aspects of the disease and patient preferences.
(B) A 76-year-old retired engineer with chronic heart failure, severe asthma and high blood pressure. He lives with his 73-year-old wife who cares for him, while herself suffering from arthritis. They live on the third floor in a housing block and are increasingly housebound due to their illness. They are determined to remain independent; their grandson, who lives nearby, does the daily shopping for them.
Both husband and wife are covered by health insurance due to their age and have free access to the health care system.
The first diagnoses are generally made by the GP who manages their day-to-day treatment. Diagnosis and treatment are coordinated according to respective guidelines, with diagnosis verified during a specialist consultation which is also used to fine-tune the treatment, incorporating specialist expertise and additional testing in specialist care. The patient may be admitted to hospital for further testing and treatment ‘calibration’. Selection of a specific ward depends on which disease is currently affecting patient’s health the most. During hospitalization, treatments provided by cardiologists or pulmonologists will be coordinated by the main treating doctor. Follow-up visits after hospitalization are scheduled before discharge. All relevant data from specialist consultations are channelled back to the GP, indicating whether nursing or social care may be needed by the patient.
Patient management on the primary care level could include regular visits by a primary care nurse and GP, if the patient is not able to visit the GP practice in person and their health situation calls for home visits. The couple’s grandson could receive financial support from the social care system for the care he provides to his grandparents, in addition to support from a trained social worker or home nurse.
5.4. Summary and conclusion
There is currently no explicit strategy in Estonia that fully encompasses the systematic management of chronic diseases. However, elements of such a vision are emerging, involving four main components: a central role of GPs; the development of treatment guidelines by medical specialties; the strategic development of plans for specialties; and the development of care centres for selected conditions.
Thus, one of the most important reforms in the Estonian health system has been the establishment of the GP system as the cornerstone for health care delivery, with GPs acting as gatekeepers to specialist care and the coordinator of care for their patients, supported by a well-developed information system and elements of pay-for-performance for the management of hypertension and type 2 diabetes.
Second, treatment guidelines as developed by medical associations (specialties) in cooperation with EHIF form widely accepted guides for conditions such as diabetes, chronic heart disease, multiple sclerosis and others. These also include so-called ‘specialty specific activity guidelines’, such as activity guidelines for home care nurses and primary health care nurses, both of which addressing the management of chronic diseases through for example stipulating the need for proactive patient follow-up, primary health care teams and coordination of activities with social care and other medical specialties.
Third, there are strategic development plans for specialties, for example, for primary health care nursing, home care nursing and GPs of relevance for the management of chronic disease such as improving and coordinating patient access to primary, secondary and tertiary health care, rehabilitation and social care.
Finally, care centres for conditions such as multiple sclerosis and type 2 diabetes build around acute hospital care units in central hospitals by adding chronic disease management and rehabilitation options and providing links with patient organizations and social care.
Overall, these four components can be seen to form a strong basis for the further development of chronic disease management in Estonia; however there remains considerable room for the further advancement of coordination and targeted action to uncover its full potential.
- Estonia - Assessing Chronic Disease Management in European Health SystemsEstonia - Assessing Chronic Disease Management in European Health Systems
- sialin isoform X3 [Mus musculus]sialin isoform X3 [Mus musculus]gi|755530113|ref|XP_011241039.1|Protein
- MULTISPECIES: 16S rRNA (guanine(527)-N(7))-methyltransferase RsmG [Rhizobium]MULTISPECIES: 16S rRNA (guanine(527)-N(7))-methyltransferase RsmG [Rhizobium]gi|499973348|ref|WP_011654066.1|Protein
- Micromonas commoda predicted protein partial mRNAMicromonas commoda predicted protein partial mRNAgi|255088198|ref|XM_002505976.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...